© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Quincy Chu, MD, associate professor, medical oncologist, University of Alberta, discusses the development of ceritinib.
Quincy Chu, MD, associate professor, medical oncologist, University of Alberta, discusses the development of ceritinib.
Clinical Pearls: